Delayed pituitary apoplexy in patient with advanced prostate cancer treated with gonadotrophin-releasing hormone agonists
Authors:
- M. SinnaduraiMSM. Sinnadurai
- R.K. CherukuriRCR.K. Cherukuri
- R.G. MosesRMR.G. Moses
- E. NasserENE. Nasser
- 1 September 2010
- journal article
- case report
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 17 (9) , 1201-1203
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Gonadotropin-Releasing Hormone Agonist-Induced Pituitary Apoplexy in Treatment of Prostate Cancer: Case Report and Review of LiteratureEndocrine Practice, 2007
- Discovery of a pituitary adenoma following a gonadotropin-releasing hormone agonist in a patient with prostate cancerInternational Journal of Urology, 2006
- Pituitary tumour pathogenesisBritish Medical Bulletin, 2006
- Rapid onset of pituitary apoplexy after goserelin implant for prostate cancer: need for heightened awarenessInternal Medicine Journal, 2001
- Pituitary apoplexy of a gonadotroph adenoma following gonadotrophin releasing hormone agonist therapy for prostatic cancerJournal of Endocrinological Investigation, 1997
- Pituitary apoplexy after leuprolide administration for carcinoma of the prostateClinical Endocrinology, 1996
- Pituitary apoplexy caused by GnRH-agonist treatment revealing gonadotroph adenomaThe Journal of Clinical Endocrinology & Metabolism, 1995
- Pituitary apoplexy after goserelinThe Lancet, 1995